CA125 decline in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy

Contrary to the assumption that IP chemotherapy elevates CA125 levels due to peritoneal irritation, these results show a trend towards faster time to CA125 normalization and nadir, and significantly lower CA125 levels during therapy for patients responding to IP chemotherapy compared with patients responding to IV therapy.